| 12083088 |
Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases |
Oliver Yoa-Pu Hu, Tung-Yuan Shih, Hsin-Tien HO |
2024-09-10 |
| 11285123 |
Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases |
Oliver Yoa-Pu Hu, Tung-Yuan Shih, Hsin-Tien HO |
2022-03-29 |
| 10976322 |
Galactose oral composition and use thereof |
Oliver Yoa-Pu Hu, Ping Yang |
2021-04-13 |
| 10456371 |
Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases |
Oliver Yoa-Pu Hu, Tung-Yuan Shih, Hsin-Tien HO |
2019-10-29 |
| 9415034 |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B) |
Yoa-Pu Hu Oliver, Mei-Ting Wang, Li-Heng Pao |
2016-08-16 |
| 7169763 |
Cytochrome P450 3A inhibitors and enhancers |
Oliver Yoa-Pu Hu, Benjamin Pei-Chung Kuo, Li-Heng Pao |
2007-01-30 |
| 6703398 |
Orally administered analgesic compositions containing nalbuphine |
Oliver Yoa-Pu Hu |
2004-03-09 |
| 6680067 |
Controlled-release pharmaceutical preparation containing nalbuphine and a process for preparing the same |
Oliver Yoa-Pu Hu |
2004-01-20 |
| 6544954 |
Stable galactose injection solutions |
Oliver Yoa-Pu Hu |
2003-04-08 |